BDXBecton, Dickinson and Company

$59B

Q4 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.6B+4.1% YoY

Gross Profit

$2.3B49.4% margin

Operating Income

$111M2.4% margin

Net Income

$162M3.5% margin

EPS (Diluted)

$0.41

QoQ Revenue Growth

+5.4%

Cash Flow

Operating Cash Flow

$1.4B

Free Cash Flow

$1.0B

Stock-Based Comp.

$53M

Balance Sheet

Total Assets

$51.8B

Total Liabilities

$30.7B

Stockholders' Equity

$21.1B

Cash & Equivalents

$536M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.6B	$4.4B	+4.1%
Gross Profit	$2.3B	$2.1B	+8.4%
Operating Income	$111M	$571M	-80.6%
Net Income	$162M	-$135M	+220.0%

Revenue Segments

Medical

$2.4B53%

Life Sciences

$1.1B25%

Interventional

$1.0B22%

Geographic Segments

UNITED STATES

$2.6B56%

Non-US

$2.0B44%

BDX Q4 2019 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena